Eucrates Biomedical Acqui...

NASDAQ: EUCRU · Real-Time Price · USD
10.02
-0.07 (-0.69%)
At close: Apr 26, 2023, 9:59 PM

Eucrates Biomedical Acquisition Cash Flow Statement

Financials in USD. Fiscal year is January - December.
Fiscal Year FY 2022 FY 2021
Period Ending Dec 31, 2022 Dec 31, 2021
Net Income
2.42M 3.82M
Depreciation & Amortization
n/a n/a
Stock-Based Compensation
n/a n/a
Other Working Capital
n/a n/a
Other Non-Cash Items
-3.12M -4.57M
Deferred Income Tax
n/a n/a
Change in Working Capital
68.29K 240.96K
Operating Cash Flow
-630.29K -502.11K
Capital Expenditures
n/a n/a
Cash Acquisitions
n/a n/a
Purchase of Investments
n/a n/a
Sales Maturities Of Investments
n/a n/a
Other Investing Acitivies
93.19M n/a
Investing Cash Flow
93.19M n/a
Debt Repayment
n/a n/a
Common Stock Repurchased
-93.19M n/a
Dividend Paid
n/a n/a
Other Financial Acitivies
-92.59M n/a
Financial Cash Flow
-92.59M n/a
Net Cash Flow
-30.29K -502.11K
Free Cash Flow
-630.29K -502.11K